Health and Fitness Health and Fitness
Fri, February 22, 2013
[ Fri, Feb 22nd 2013 ] - Market Wire
Biotech Companies Receive Drug Approvals
[ Fri, Feb 22nd 2013 ] - Market Wire
AdCare Health Systems to Present at the 25th Annual ROTH Conference
[ Fri, Feb 22nd 2013 ] - Market Wire
Once-a-Week Insulin Shot Could Help Growing Diabe .. Patient Base and Spell Huge Profits for Investors
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Leisureworld Senior Care Corporation Reports Strong 2012 Fourth Quarter and Year End Results
[ Thu, Feb 21st 2013 ] - Market Wire
Cempra, Inc. to Report Fourth Quarter and Full Ye .. ing Results, and Host Conference Call and Webcast
[ Thu, Feb 21st 2013 ] - Market Wire
Syneron Settles U.S. Patent Infringement Lawsuit with EndyMed and Eclipse Aesthetics
[ Thu, Feb 21st 2013 ] - Market Wire
Edwards Lifesciences to Present at the Citigroup and RBC 2013 Global Healthcare Conferences
[ Thu, Feb 21st 2013 ] - Market Wire
Health Sciences Group Files OTC Full Disclosures &;; Financials to Update Tier Status
[ Thu, Feb 21st 2013 ] - Market Wire
Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers
[ Thu, Feb 21st 2013 ] - Market Wire
NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
[ Thu, Feb 21st 2013 ] - Market Wire
Life Technologies to Present at Barclays Global Healthcare Conference
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
[ Thu, Feb 21st 2013 ] - Market Wire
Milestone Scientific to Conduct Live Presentation on Boardvote.com
[ Thu, Feb 21st 2013 ] - Market Wire
Digirad Corporation Launches Molecular Breast Ima .. ssory for Expanded Use of ergo(TM) Imaging System
[ Thu, Feb 21st 2013 ] - Market Wire
VentriPoint Announces 3D Ultrasound Heart Analysis System and Prepares for Clinical Release
[ Thu, Feb 21st 2013 ] - Market Wire
Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on February 27
Wed, February 20, 2013
[ Wed, Feb 20th 2013 ] - Market Wire
Thallion Announces 2012 Fourth Quarter and Year End Operating Results
[ Wed, Feb 20th 2013 ] - Market Wire
ResMed Appoints Michael Farrell as Chief Executiv .. glas Appointed President and Chief Operating Offi
[ Wed, Feb 20th 2013 ] - Market Wire
Bernstein Liebhard LLP Announces That Only Six Da .. r Lead Plaintiff In A Class Action Against Isis P
[ Wed, Feb 20th 2013 ] - Market Wire
Johnson amp;; Johnson to Participate in 2013 Citi Global Health Care Conference
[ Wed, Feb 20th 2013 ] - Market Wire
AbbVie to Present at Cowen and Company 33rd Annual Health Care Conference
[ Wed, Feb 20th 2013 ] - Market Wire
Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
[ Wed, Feb 20th 2013 ] - Market Wire
Addus HomeCare Announces Filing of Complaint Seeking Temporary Restraining Order
[ Wed, Feb 20th 2013 ] - Market Wire
Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference
[ Wed, Feb 20th 2013 ] - Market Wire
Thallion Initiates Strategic Review Process
[ Wed, Feb 20th 2013 ] - Market Wire
Thallion and LFB Terminate Shigamabs Collaboration
[ Wed, Feb 20th 2013 ] - Market Wire
PDL BioPharma to Present at Two Upcoming Investor Conferences
[ Wed, Feb 20th 2013 ] - Market Wire
EnteroMedics Names Greg S. Lea Chief Operating Officer
[ Wed, Feb 20th 2013 ] - Market Wire
OrbusNeich Files Patent Infringement Actions Agai .. Boston Scientific in Germany and the Netherlands
Tue, February 19, 2013
[ Tue, Feb 19th 2013 ] - Market Wire
Merus Labs International Inc. Announces Promotion .. greements for Emselex(R)/Enablex(R) in Canada &am
[ Tue, Feb 19th 2013 ] - Market Wire
Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
[ Tue, Feb 19th 2013 ] - Market Wire
Graphite Corp. Updates Grid Survey Activities at Historically Productive Alabama Property
[ Tue, Feb 19th 2013 ] - Market Wire
Peregrine Pharmaceuticals Updates Top-Line Data F .. of Bavituximab in Second-Line Non-Small Cell Lung
[ Tue, Feb 19th 2013 ] - Market Wire
Orphan Drug Catalyst Pushing DARA Shares Toward Possible Technical Break-Out
[ Tue, Feb 19th 2013 ] - Market Wire
Biotech Stocks Offers Healthy Returns
[ Tue, Feb 19th 2013 ] - Market Wire
Shire's VPRIV Wins First Ever quot;;Novel .. From Lysosomal Disease Network at Their 9th WORLD
[ Tue, Feb 19th 2013 ] - Market Wire
AcelRx Pharmaceuticals Provides Clinical Trial Updates
[ Tue, Feb 19th 2013 ] - Market Wire
Congressman John Tierney Visits Implant Sciences
[ Tue, Feb 19th 2013 ] - Market Wire
VentriPoint Provides Update on VMS(TM) Product Development and Ongoing Clinical Research
[ Tue, Feb 19th 2013 ] - Market Wire
GSK and Theravance Announce FDA Acceptance of New .. bmission in the US for ANORO ELLIPTA(TM) for COPD
[ Tue, Feb 19th 2013 ] - Market Wire
OncoSec Medical Promotes Veronica Vallejo to Chief Financial Officer
[ Tue, Feb 19th 2013 ] - Market Wire
United Therapeutics Corporation To Announce Fourt .. ancial Results Before Market Open On Tuesday, Feb
Mon, February 18, 2013
[ Mon, Feb 18th 2013 ] - Market Wire
Regeneron and Bayer Initiate Phase 3 Trial of EYL .. r the Treatment of Diabetic Macular Edema in Asia
[ Mon, Feb 18th 2013 ] - Market Wire
HealthSouth Announces Increase In Authorization To Repurchase Common Stock Up To $350 Million
[ Mon, Feb 18th 2013 ] - Market Wire
Hansen Medical to Present at 33rd Annual Cowen Healthcare Conference
[ Mon, Feb 18th 2013 ] - Market Wire
Remedent Announces Exclusive Agreement With Biote .. Aesthetic SAS in Reference to Its Product River 8
[ Mon, Feb 18th 2013 ] - Market Wire
Oramed Pharmaceuticals to Present at the 4th Annu .. elivery amp;; Formulation Summit in Berlin
[ Mon, Feb 18th 2013 ] - Market Wire
Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
[ Mon, Feb 18th 2013 ] - Market Wire
Intraocular Lens (IOL): Market Shares, Strategies .. orecasts, Worldwide, Nanotechnology, 2013 to 2018
[ Mon, Feb 18th 2013 ] - Market Wire
Alchemia Achieves $3.4 Million Quarterly Fondaparinux Profit Share
[ Mon, Feb 18th 2013 ] - Market Wire
Alchemia Appoints Charles Walker as Chief Executive Officer
Sun, February 17, 2013
[ Sun, Feb 17th 2013 ] - Market Wire
Diamydas major shareholders reach agreement
Fri, February 15, 2013
[ Fri, Feb 15th 2013 ] - Market Wire
Masimo Continues Its Advocacy on Behalf of Newbor .. ing Congenital Heart Defects (CHD) Awareness Week
[ Fri, Feb 15th 2013 ] - Market Wire
Alere to Attend the J.P. Morgan High Yield & Leveraged Finance Conference on February 26th
[ Fri, Feb 15th 2013 ] - Market Wire
Alere to Attend the J.P. Morgan High Yield amp .. 59; Leveraged Finance Conference on February 26th
[ Fri, Feb 15th 2013 ] - Market Wire
(OTCQB: CBIS), (OTCQB: XCHC), and (OTCQB: PHOT)
[ Fri, Feb 15th 2013 ] - Market Wire
Investment in a Qubec public-private partnership .. lized medicine solutions in the treatment of canc
[ Fri, Feb 15th 2013 ] - Market Wire
Dako Receives FDA Approval for Fast, Accurate, Nontoxic FISH Assay for Cancer Diagnostics
[ Fri, Feb 15th 2013 ] - Market Wire
AbbVie Declares Dividend and Announces Share Repurchase Program
[ Fri, Feb 15th 2013 ] - Market Wire
International Stem Cell Corporation Strengthens Intellectual Property Portfolio
[ Fri, Feb 15th 2013 ] - Market Wire
NW Bio Takes Next Steps In Moving Forward With Its Phase III Brain Cancer Trial In Europe
[ Fri, Feb 15th 2013 ] - Market Wire
Extendicare Announces February 2013 Dividend of C$0.07 Per Share
[ Fri, Feb 15th 2013 ] - Market Wire
VentriPoint Founder Giving Invited Lecture at International Congress
[ Fri, Feb 15th 2013 ] - Market Wire
BAROnova Secures $27.3M Investment To Fund Clinical Trial For Weight-loss Device
[ Fri, Feb 15th 2013 ] - Market Wire
Remedent Announces Conference Call to Be Held on .. at 11 AM EST to Give an Update on Recent Strategi
Thu, February 14, 2013
[ Thu, Feb 14th 2013 ] - Market Wire
Sean P. Nolan Joins InterMune as Executive Vice President and Chief Business Officer
[ Thu, Feb 14th 2013 ] - Market Wire
Cantel Medical To Present At RBC Capital Markets Healthcare Conference
[ Thu, Feb 14th 2013 ] - Market Wire
STATS ChipPAC Announces Private Exchange Offer fo .. 015 and Potential Concurrent Private Placement of
[ Thu, Feb 14th 2013 ] - Market Wire
New Research Shows Significant Benefits of Medtro .. ion Earlier in Progression of Parkinson's Disease
[ Thu, Feb 14th 2013 ] - Market Wire
Actavis Reaches Settlement with Mallinckrodt Over Exalgo 32 mg Dosage Strength
[ Thu, Feb 14th 2013 ] - Market Wire
Theratechnologies to Announce Financial Results for Fiscal Year 2012
[ Thu, Feb 14th 2013 ] - Market Wire
USANA True Health Foundation Sponsors 777 Project .. Man To Run 7 Marathons In 7 Days On 7 Continents
[ Thu, Feb 14th 2013 ] - Market Wire
Hansen Medical Appoints Will Sutton as Chief Oper .. cer Responsible for Engineering and Manufacturing
[ Thu, Feb 14th 2013 ] - Market Wire
NxStage Initiates 2013 'Call to Action' Campaign .. odialysis At Home: A Better Way For a Better Life
[ Thu, Feb 14th 2013 ] - Market Wire
New Analysis Shows Age has a Significant Effect o .. Treated for Clostridium difficile Infection (CDI)
[ Thu, Feb 14th 2013 ] - Market Wire
Haemonetics' CMO, Mark Popovsky, Joins U.S. Healt .. Human Services Advisory Committee on Blood Safety
[ Thu, Feb 14th 2013 ] - Market Wire
Santa Fe Petroleum, Inc. Announces Purchase of Oil amp;; Gas Leases for Additional Drilling
[ Thu, Feb 14th 2013 ] - Market Wire
FONAR Reports 12 Straight Quarters of Net Income .. ght Quarters of Profitability Greater Than $1.5 M
Wed, February 13, 2013
[ Wed, Feb 13th 2013 ] - Market Wire
Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
[ Wed, Feb 13th 2013 ] - Market Wire
Endo to Announce Fourth Quarter 2012 Financial Results on February 28, 2013
[ Wed, Feb 13th 2013 ] - Market Wire
Hill-Rom to Participate in the 2013 Citi Global Healthcare Conference
[ Wed, Feb 13th 2013 ] - Market Wire
University of Tsukuba Hospital neurosurgeons perf .. ently installed VISIUS Surgical Theatre with iMRI
[ Wed, Feb 13th 2013 ] - Market Wire
Verisante Named Edison Awards Finalist
[ Wed, Feb 13th 2013 ] - Market Wire
Vivakor Issues Shareholder Update With Results From 2012 Financials and Outlook for 2013
[ Wed, Feb 13th 2013 ] - Market Wire
BIOLASE to Host Fourth Quarter Financial Results Conference Call on March 6, 2013
[ Wed, Feb 13th 2013 ] - Market Wire
CryoLife Announces Quarterly Cash Dividend for the First Quarter 2013
[ Wed, Feb 13th 2013 ] - Market Wire
Peregrine Pharmaceuticals Announces Results From .. rial of Bavituximab in Stage IV Pancreatic Cancer
[ Wed, Feb 13th 2013 ] - Market Wire
TSO3 Announces CDN $ 7,000,000 Offering on a Bought Deal Basis
[ Wed, Feb 13th 2013 ] - Market Wire
Haemonetics to Present at Citi 2013 Global Healthcare Conference
[ Wed, Feb 13th 2013 ] - Market Wire
Implant Sciences Announces Additional Contract Award in Singapore
Tue, February 12, 2013
[ Tue, Feb 12th 2013 ] - Market Wire
Corcept Therapeutics Announces Fourth Quarter and Full Year Revenue and Corporate Update
[ Tue, Feb 12th 2013 ] - Market Wire
Quidel Reports Fourth Quarter and Full Year 2012 Financial Results
[ Tue, Feb 12th 2013 ] - Market Wire
Promus PREMIERa" Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval
[ Tue, Feb 12th 2013 ] - Market Wire
CareFusion Launches New Take-Apart Laparoscopic Scissors
[ Tue, Feb 12th 2013 ] - Market Wire
Faruqi amp;; Faruqi, LLP is Investigating .. Corporation on Behalf of its Shareholders - RPTP
[ Tue, Feb 12th 2013 ] - Market Wire
Micro Imaging Technology Announces Paradigm Shift .. oviding Software-Based Identification of Microbes
[ Tue, Feb 12th 2013 ] - Market Wire
BioSyent Presents at MicroCapClub Invitational
[ Tue, Feb 12th 2013 ] - Market Wire
AcelRx Appoints Adrian Adams to Board of Directors as Chairman
[ Tue, Feb 12th 2013 ] - Market Wire
Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual Meeting
[ Tue, Feb 12th 2013 ] - Market Wire
Biota Pharmaceuticals Reports Second Quarter Financial Results and Corporate Update
[ Tue, Feb 12th 2013 ] - Market Wire
Sirona Biochem's Cosmetic Skin Lightening Compoun .. s Proven Safe in Industry Standard Irritant Study
[ Tue, Feb 12th 2013 ] - Market Wire
Comprehensive Care Corporation Announces New Medi .. tract with Humana Health Plan of California, Inc.
Mon, February 11, 2013
[ Mon, Feb 11th 2013 ] - Market Wire
Hamilton Thorne Announces Preliminary 2012 Fourth Quarter Financial Results
[ Mon, Feb 11th 2013 ] - Market Wire
LifeSci Advisors Initiates Coverage of Navidea Biopharmaceuticals
[ Mon, Feb 11th 2013 ] - Market Wire
Implant Sciences' QS-B220 to Be Featured at Security Conference in Russia
[ Mon, Feb 11th 2013 ] - Market Wire
Perrigo Company Acquires U.K.-based Rosemont Phar .. td. For Approximately 180 Million Or $283 Million
[ Mon, Feb 11th 2013 ] - Market Wire
NW Bio To Present At 15th Annual BIO CEO amp;; Investor Conference
[ Mon, Feb 11th 2013 ] - Market Wire
Vasomedical, Inc. Investor Presentation Now Avail .. n-demand Viewing at RetailInvestorConferences.com
[ Mon, Feb 11th 2013 ] - Market Wire
Mylan Appoints Melina Higgins and Rajiv Malik to Board of Directors
[ Mon, Feb 11th 2013 ] - Market Wire
Horizon Pharma Announces Preliminary Fourth Quart .. s, Full U.S. Commercial Launch of RAYOS(R) (Predn
[ Mon, Feb 11th 2013 ] - Market Wire
MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
[ Mon, Feb 11th 2013 ] - Market Wire
Aethlon Medical, Inc. Investor Presentation Now A .. n-demand Viewing at RetailInvestorConferences.com
[ Mon, Feb 11th 2013 ] - Market Wire
Ampio forms Luoxis Diagnostics to Commercialize ORP Technology
[ Mon, Feb 11th 2013 ] - Market Wire
Zynga, Inc. Fourth-Quarter Earnings and Sales Topped Wall Street Estimates
Sun, February 10, 2013
[ Sun, Feb 10th 2013 ] - Market Wire
Helix BioPharma Announces Director Resignation
Fri, February 8, 2013
[ Fri, Feb 08th 2013 ] - Market Wire
La Administracin de Alimentos y Medicamentos de E .. idomida) para el tratamiento de pacientes con mie
[ Fri, Feb 08th 2013 ] - Market Wire
L'agenzia per gli alimenti e medicinali degli Sta .. e a POMALYST per la cura di pazienti affetti da m
[ Fri, Feb 08th 2013 ] - Market Wire
US-amerikanische FDA erteilt Zulassung fr POMALYS .. ng von Patienten mit rezidiviertem und refraktrem
[ Fri, Feb 08th 2013 ] - Market Wire
Gilead Sciences schliet bernahme von YM BioSciences ab
[ Fri, Feb 08th 2013 ] - Market Wire
Verisante Technology, Inc. Retains Hamza Thindal Capital Corp. for Investor Relations
[ Fri, Feb 08th 2013 ] - Market Wire
30 a.m. ET February 15, 2013 to Discuss Fourth Quarter 2012 Results
[ Fri, Feb 08th 2013 ] - Market Wire
Today's Research on Hologic and St. Jude Medical: .. re Act Ultimately be Beneficial for the Industry?
[ Fri, Feb 08th 2013 ] - Market Wire
Shire Regenerative Medicine Initiates Phase 3 Stu .. of ABH001 for Patients with Epidermolysis Bullosa
[ Fri, Feb 08th 2013 ] - Market Wire
HeartWare Presentation at Leerink Swann Global Healthcare Conference to be Webcast
[ Fri, Feb 08th 2013 ] - Market Wire
3SBio Inc. Enters Into Merger Agreement For quot;;Going Privatequot;; Transaction
[ Fri, Feb 08th 2013 ] - Market Wire
3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction
[ Fri, Feb 08th 2013 ] - Market Wire
Accuray Prices Offering Of $100 Million Of 3.50% Convertible Senior Notes
Thu, February 7, 2013
[ Thu, Feb 07th 2013 ] - Market Wire
Vigil Health Solutions Reports Revenue/Bookings G .. ng in Profitable Quarter and Year to Date Results
[ Thu, Feb 07th 2013 ] - Market Wire
PROLASTIN comemora 25 anos como principal tratame .. e reposio para deficincia de alfa(1)-antitripsina
[ Thu, Feb 07th 2013 ] - Market Wire
Zhengzhou neurosurgeons perform first iMRI case in VISIUS Surgical Theatre
[ Thu, Feb 07th 2013 ] - Market Wire
Implant Sciences Receives Patent for New Trace Particle Collection System
[ Thu, Feb 07th 2013 ] - Market Wire
Vista Partners Publishes February 2013 Macroeconomic &;; Investment Newsletter
[ Thu, Feb 07th 2013 ] - Market Wire
biOasis Announces Positive Anti-Tumour Efficacy Data
[ Thu, Feb 07th 2013 ] - Market Wire
Venaxis Executes First Commercial Development Agr .. Order from EMELCA Bioscience for Initial EU Launc
[ Thu, Feb 07th 2013 ] - Market Wire
Rigel to Present at BIO CEO amp;; Investor Conference
[ Thu, Feb 07th 2013 ] - Market Wire
Pharma Stocks Look Forward to Shoot up
[ Thu, Feb 07th 2013 ] - Market Wire
Isis Pharmaceuticals to Present at the 2013 Leerink Swann Global Healthcare Conference
[ Thu, Feb 07th 2013 ] - Market Wire
Addus HomeCare Announces Definitive Agreement to .. l Assets of its Home Health Division to LHC Group
[ Thu, Feb 07th 2013 ] - Market Wire
Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
Wed, February 6, 2013
[ Wed, Feb 06th 2013 ] - Market Wire
Cadence Pharmaceuticals' CEO Ted Schroeder To Pre .. bal Healthcare Conference In New York City On Feb
[ Wed, Feb 06th 2013 ] - Market Wire
PROLASTIN celebra sus 25 aos como principal terap .. ratamiento de la deficiencia alfa(1)-antitripsina
[ Wed, Feb 06th 2013 ] - Market Wire
Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
[ Wed, Feb 06th 2013 ] - Market Wire
Pharma Stocks Deal with Drug Developments and Patents
[ Wed, Feb 06th 2013 ] - Market Wire
Omni Bio Pharmaceutical Appoints Dr. Michael Kamarck as New Director
[ Wed, Feb 06th 2013 ] - Market Wire
BIOLASE Receives FDA Clearance for Its 940nm Diol .. Laser for a Broad Spectrum of Medical Procedures
[ Wed, Feb 06th 2013 ] - Market Wire
Cynosure to Participate in Leerink Swann Global Healthcare Conference 2013
[ Wed, Feb 06th 2013 ] - Market Wire
Horizon Pharma Announces the U.S. Patent and Trad .. onal Notice of Allowance With Claims Covering RAY
[ Wed, Feb 06th 2013 ] - Market Wire
Sunshine's Short Squeeze Play Warms Bullish Investors
[ Wed, Feb 06th 2013 ] - Market Wire
Aethlon Medical, Inc. to Webcast, Live, at Retail InvestorConferences.com on February 7th
[ Wed, Feb 06th 2013 ] - Market Wire
Lexicon To Present At The BIO CEO amp;; Investor Conference
[ Wed, Feb 06th 2013 ] - Market Wire
OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
Tue, February 5, 2013
[ Tue, Feb 05th 2013 ] - Market Wire
Mesa Labs Reports 18% Increase in Third Quarter Revenues
[ Tue, Feb 05th 2013 ] - Market Wire
Immunovaccine Announces a Proposed Equity Offering
[ Tue, Feb 05th 2013 ] - Market Wire
Cempra, Inc. to Present at BIO CEO amp;; I .. ce and Leerink Swann Global Healthcare Conference
[ Tue, Feb 05th 2013 ] - Market Wire
Vivakor Announces Completion of Precious Metal Pr .. Through Its VivaVentures Precious Metals Division
[ Tue, Feb 05th 2013 ] - Market Wire
Metastatic Brain Cancer Video Released by Cornell Weill
[ Tue, Feb 05th 2013 ] - Market Wire
Theratechnologies Announces Completion of NASDAQ Delisting
[ Tue, Feb 05th 2013 ] - Market Wire
Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
[ Tue, Feb 05th 2013 ] - Market Wire
The Better Way Back(R), a NuVasive(R) Patient Education Program, Reaches 1,000 Patient Ambassadors
[ Tue, Feb 05th 2013 ] - Market Wire
DiaMedica to Present at 15th Annual BIO CEO &;; Investor Conference
[ Tue, Feb 05th 2013 ] - Market Wire
China Botanic Pharmaceutical Inc. Announces Recei .. Failure to Satisfy Continued Listing Requirements
[ Tue, Feb 05th 2013 ] - Market Wire
Horizon Pharma Announces Receipt of Additional U.S. Patent Allowance for DUEXIS(R)
[ Tue, Feb 05th 2013 ] - Market Wire
Implant Sciences' Desktop Trace Detector Purchase .. vice for Explosives &;; Drugs Screening
Mon, February 4, 2013
[ Mon, Feb 04th 2013 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against Keryx Biopharmaceutical
[ Mon, Feb 04th 2013 ] - Market Wire
PITOOEY!(TM) Receives Official Endorsement From M .. ants (changing its name from White Dental Supply)
[ Mon, Feb 04th 2013 ] - Market Wire
Cyberonics Announces Update On Hagerty Lawsuit
[ Mon, Feb 04th 2013 ] - Market Wire
Alere to Attend the Leerink Swann Global Healthcare Conference on February 13th
[ Mon, Feb 04th 2013 ] - Market Wire
First Patient Treated Worldwide with the new CyberKnife M6a" System
[ Mon, Feb 04th 2013 ] - Market Wire
Sarepta Therapeutics to Present Company Overview at the Leerink Swann Global Healthcare Conference
[ Mon, Feb 04th 2013 ] - Market Wire
Solta Medical to Present at the Leerink Swann Glo .. hcare Conference in New York on February 14, 2013
[ Mon, Feb 04th 2013 ] - Market Wire
Venaxis, Inc. to Webcast Live at RetailInvestorConferences.com on February 7, 2013
[ Mon, Feb 04th 2013 ] - Market Wire
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
[ Mon, Feb 04th 2013 ] - Market Wire
Novadaq to Present at February Investor Healthcare Conferences
[ Mon, Feb 04th 2013 ] - Market Wire
Sequenom CMM's MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities
[ Mon, Feb 04th 2013 ] - Market Wire
BioLife Solutions Appoints Rick Stewart To Board of Directors
Sun, February 3, 2013
[ Sun, Feb 03rd 2013 ] - Market Wire
Covidien anuncia Entrega da Declarao de Registro .. Ciso Planejada do Negcio de Produtos Farmacuticos
Sat, February 2, 2013
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. Arzneimittel zur Behandlung der zugrunde liegende
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. rzneimittel zur Behandlung der zugrunde liegenden
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ; das erste Arzneimittel zur Behandlung der z
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ;; das erste Arzneimittel zur Behandlung d
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ;;; das erste Arzneimittel zur Behandlu
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ;;;; das erste Arzneimittel zur Beha
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. 9;;;;;; das erste Arzneimittel
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ;;;;;;;;;;; das
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ;;;;;;;;;;;;&
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ;;;;;;;;;;;;&
[ Sat, Feb 02nd 2013 ] - Market Wire
Republik Irland bewilligt Kostenbernahme fr KALYD .. ;;;;;;;;;;;;&
[ Sat, Feb 02nd 2013 ] - Market Wire
Covidien anuncia la presentacin del Formulario 10 .. relativa a la escisin planificada del negocio de
Fri, February 1, 2013
[ Fri, Feb 01st 2013 ] - Market Wire
Covidien annuncia il deposito della dichiarazione .. 0 per lo spin-off pianificato della Divisione far
[ Fri, Feb 01st 2013 ] - Market Wire
Covidien meldet Einreichung des Registrierungsdok .. rbindung mit der geplanten Ausgliederung des Phar
[ Fri, Feb 01st 2013 ] - Market Wire
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against Keryx Biopharmaceuticals, Inc. -- KERX
[ Fri, Feb 01st 2013 ] - Market Wire
Faruqi amp;; Faruqi, LLP Files Class Actio .. it Against Keryx Biopharmaceuticals, Inc. -- KERX
[ Fri, Feb 01st 2013 ] - Market Wire
Auxilium Pharmaceuticals, Inc. Announces IMPRESS .. 's Disease Were Published Online in The Journal o
[ Fri, Feb 01st 2013 ] - Market Wire
Accreditation With Exemplary Standing Awarded to Preferred Health Care Services
[ Fri, Feb 01st 2013 ] - Market Wire
Shire Reaches Agreement in Principle With U.S. Government
[ Fri, Feb 01st 2013 ] - Market Wire
PITOOEY! CEO Appears in Radio Interview to Promot .. he Apple iTunes App Store (changing its name from
[ Fri, Feb 01st 2013 ] - Market Wire
Healthpoint Biotherapeutics Introduces Copay Assistance Program For Collagenase Santyl Ointment
[ Fri, Feb 01st 2013 ] - Market Wire
CML HealthCare Inc. Receives OBSP Affiliation at .. ket Imaging Clinic-Open House on February 2, 2013
[ Fri, Feb 01st 2013 ] - Market Wire
Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
[ Fri, Feb 01st 2013 ] - Market Wire
Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Helix BioPharma Announces Director Resignation


//health-fitness.news-articles.net/content/2013/ .. ix-biopharma-announces-director-resignation.html
Published in Health and Fitness on Sunday, February 10th 2013 at 8:30 GMT by Market Wire   Print publication without navigation


February 10, 2013 11:01 ET

Helix BioPharma Announces Director Resignation

AURORA, ON--(Marketwire - Feb 10, 2013) -  Helix BioPharma Corp. (TSX: [ HBP ]) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, announced that on Friday, February 8, 2013 John A. Rogers has voluntarily resigned from Helix's board of directors.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its novel L-DOS47 new drug candidate and its Topical Interferon Alpha-2b. Helix is currently listed on the TSX and FSE under the symbol "HBP."



Publication Contributing Sources